These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3660443)

  • 1. Mechanisms of hepatocyte necrosis in HBV hepatitis.
    Kamat RS; Naik SR
    Trop Gastroenterol; 1987; 8(2):59-66. PubMed ID: 3660443
    [No Abstract]   [Full Text] [Related]  

  • 2. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
    Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
    Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of HBeAg/anti-HBe status and its relationship to clinical and histological outcome in chronic HBV carriers in childhood.
    Sodeyama T; Kiyosawa K; Akahane Y; Tanaka E; Wada S; Oike Y; Nakamura M; Yoda H; Imai Y; Gibo Y
    Am J Gastroenterol; 1986 Apr; 81(4):239-45. PubMed ID: 3962948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune mechanisms in inflammatory liver diseases].
    Hütteroth TH; Poralla T; Meyer zum Büschenfelde KH
    Internist (Berl); 1985 Oct; 26(10):607-13. PubMed ID: 3935596
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heterogeneity of host response to hepatitis B virus].
    Sarno EN; Ruzany F; Vieira LM; Landmann J
    Rev Inst Med Trop Sao Paulo; 1982; 24(5):303-9. PubMed ID: 7167709
    [No Abstract]   [Full Text] [Related]  

  • 6. [Liver and cellular immunity].
    Ito K; Nakano H; Sano M
    Nihon Rinsho; 1978 May; Suppl():2200-1. PubMed ID: 691695
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatitis B virus (HBV) and the inflammatory/immune response. I. The natural environment of the antigen presentation and immunologic chaos induced by the virus].
    Villarrubia VG; Alvarez-Mon M; Chirigos MA; Herrerías JM
    Rev Esp Enferm Dig; 1997 Dec; 89(12):919-28. PubMed ID: 9494379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the tumor necrosis factor-alpha system in the liver in chronic hepatitis B virus infection.
    Fang JW; Shen WW; Meager A; Lau JY
    Am J Gastroenterol; 1996 Apr; 91(4):748-53. PubMed ID: 8677942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action mechanism in immunopathogenesis and clearance of HBV].
    Im SJ; Sung YC
    Korean J Hepatol; 2006 Jun; 12(2):154-62. PubMed ID: 16804340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proceedings: Cell-mediated immunity to hepatitis B antigen in blood donors with persistent antigenaemia or high titre antibody.
    Lee WM; Reed WD; Mitchell CG; Eddleston AL; Dymock I; Williams R
    Gut; 1974 Oct; 15(10):825. PubMed ID: 4434933
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunopathology of hepatitis B virus infection.
    Tsai HT; Tsai TH; Lu TM; Yang CC
    Int Rev Immunol; 2008; 27(6):427-46. PubMed ID: 19065350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune lesion of hepatitis B].
    García Buey L; González Mateos F; García Monzón C; Moreno Otero R
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():15-28. PubMed ID: 11279891
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
    Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
    Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hepatopathy of the drug addict. Morphological data and incidence of serological markers of hepatitis B virus in 65 patients].
    Gottardi E; Di Marco G
    Minerva Med; 1984 Nov; 75(45-46):2733-9. PubMed ID: 6521944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HB carrier and onset and course of chronic hepatitis].
    Sekiya C
    Hokkaido Igaku Zasshi; 1984 May; 59(3):224-30. PubMed ID: 6207086
    [No Abstract]   [Full Text] [Related]  

  • 16. Overt and latent HBV infection.
    Bonino F; Negro F; Chiaberge E; Crivelli O
    Prog Clin Biol Res; 1983; 143():337-44. PubMed ID: 6669583
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus.
    Tsai SL; Liaw YF; Yeh CT; Chu CM; Kuo GC
    Hepatology; 1995 Apr; 21(4):908-12. PubMed ID: 7535736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology and the liver.
    Peters M; Vierling J; Gershwin ME; Milich D; Chisari FV; Hoofnagle JH
    Hepatology; 1991 May; 13(5):977-94. PubMed ID: 2030002
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cellular immune reactions against hepatitis associated antigen (HAA) and homologous liver specific antigen in acute HAA positive hepatitis].
    Knolle J; Meyer zum Büschenfelde ; Friedrichs N; Bolte JP
    Verh Dtsch Ges Inn Med; 1973; 79():639-41. PubMed ID: 4790318
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
    Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
    Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.